Belatacept Conversion Trial in Renal Transplantation
Belatacept Conversion Trial in Renal Transplantation
The purpose of this study is to learn if conversion to belatacept from cyclosporine or tacrolimus will preserve kidney function in people who have had a kidney transplant. The safety and tolerability of this treatment will also be studied
Key Inclusion Criteria:
Key Exclusion Criteria:
Chapel Hill, North Carolina 27599-7155, United States
Buenos Aires, Buenos Aires 1155, Argentina
Capital Federal, Buenos Aires C1425APQ, Argentina
Homburg/saar, 66421, Germany
Df, Mexico City 14000, Mexico